Although generally safe, hyaluronic acid rejuvenation of periorbital tissue has been reported to cause minor and major adverse events. The authors document a case of nasolacrimal duct obstruction due to hyaluronic acid rejuvenation of the tear trough. Nasolacrimal duct obstruction immediately resolved following irrigation of hyaluronidase into the affected lacrimal system. To the authors’ knowledge, this is the first reported case of nasolacrimal duct obstruction due to filler injection.
The authors present a case of nasolacrimal duct obstruction secondary to hyaluronic acid tear trough rejuvenation.
*Department of Ophthalmology, University of Montreal, Montreal, Quebec, Canada
†Department of Ophthalmology, University of California San Francisco, San Francisco, California, U.S.A.
Accepted for publication October 7, 2018.
The authors have no financial or conflicts of interest to disclose.
Address correspondence and reprint requests to Evan Kalin-Hajdu, M.D., Département d’ophtalmologie, CIUSSS de l’Est-de-l’île-de-Montréal Hôpital Maisonneuve-Rosemont, 5415, boulevard de l’Assomption, Montréal, QC H1T 2M4, Canada. E-mail: email@example.com